Selecta Biosciences

Developer of nanoparticle immunomodulatory drugs for treating multiple diseases

placeWatertown, New York, United States calendar_todayFounded 2008 groups67 employees language selectabio.com

Registered entities

Innovation

57 patent families (15 granted) — focus: Human necessities, Chemistry & metallurgy, Operations & transport, Physics & computing; filing pace slowing. Cited 27,140 times.

YearFilings
201510
201614
201714
201816
201912
202016
202116
202219
202322
202415
20255
20262

Investor mix

22 investors on record; lead investors include Rusnano, Polaris Partners, Orbimed, I2BF Global Ventures; 1 has since exited.

Investor typeCountShare
Venture capital1359%
Private equity15%
Other / undisclosed836%
Coming soon